Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Aptose Biosciences Inc. (T.APS) had Current Ratio of 2.14 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-34.85M |
|
-- |
|
-- |
|
-- |
|
-35.99M |
|
-- |
|
-34.85M |
|
-34.85M |
|
-34.85M |
|
-34.85M |
|
-34.85M |
|
-34.85M |
|
-35.99M |
|
-35.43M |
|
0.70M |
|
0.70M |
|
-49.86 |
|
-49.86 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.88M |
|
-- |
|
-- |
|
-- |
|
20.11M |
|
-6.23M |
|
-6.23M |
|
-6.23M |
|
2.01M |
|
| Cash Flow Statement Financials | |
-49.31M |
|
0.02M |
|
45.80M |
|
12.68M |
|
9.19M |
|
-3.49M |
|
1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.14 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
559.76% |
|
559.76% |
|
-251.11% |
|
559.76% |
|
-3.10 |
|
-70.51 |
|
-70.55 |
|